2 Tunxis Road
Tariffville CT 06081
Metrum Research Group is a global leader in biomedical modeling and simulation, with a track record of over 250+ R&D projects, serving more than 100 different biotech and pharma developers over the last 10 years. R&D decision-making is supported quantitatively by data scientists with extensive experience in industry, academic, and regulatory settings, across all therapeutic areas. Typical decision areas include: probability of technical success, clinical utility, pharmacokinetics/pharmacodynamics, dose selection, trial design optimization, and comparative effectiveness. We create custom teams to meet your project objectives by applying the right combination of skills, tools, and methods.
Internal R&D projects at Metrum Research Group are focused on advanced data science methods, analysis tools, computational infrastructure, and the quantitative description of specific disease areas. Current therapeutic area research programs include proprietary disease model development for Alzheimer’s Disease, bone health, Hepatitis-C, Multiple Sclerosis, oncology, pain, pediatrics, and rare disorders.